Matches in Wikidata for { <http://www.wikidata.org/entity/Q95323086> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q95323086 description "article scientifique publié en 2020" @default.
- Q95323086 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95323086 description "scientific article published on 01 May 2020" @default.
- Q95323086 description "wetenschappelijk artikel" @default.
- Q95323086 description "наукова стаття, опублікована 1 травня 2020" @default.
- Q95323086 name "Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323086 name "Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323086 type Item @default.
- Q95323086 label "Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323086 label "Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323086 prefLabel "Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323086 prefLabel "Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323086 P1433 Q95323086-C3EF4CA4-3816-4727-B112-796546765C67 @default.
- Q95323086 P1476 Q95323086-8B987FDC-0FEC-464F-A100-9F6D7616458D @default.
- Q95323086 P2093 Q95323086-03F22FB2-F1E7-4DE3-932C-8E08D12C5BD9 @default.
- Q95323086 P2093 Q95323086-29B07B46-85AB-43F2-A101-524A6EA77795 @default.
- Q95323086 P2093 Q95323086-7087D47D-2951-427C-9FF9-D55BF37D6565 @default.
- Q95323086 P2093 Q95323086-71B6052F-85DA-4E7E-9679-1ACFA2EBF6D5 @default.
- Q95323086 P2093 Q95323086-80A33CC1-D945-4EC1-AFDD-EFA15AF831AF @default.
- Q95323086 P2093 Q95323086-9EAC270F-D1A8-4B00-B15B-283F24D43140 @default.
- Q95323086 P304 Q95323086-B6223770-0D92-46F5-B2B2-B4827AAE922B @default.
- Q95323086 P31 Q95323086-2054AC56-710A-4A89-9A9E-814AC96FE718 @default.
- Q95323086 P356 Q95323086-B36CCED4-6771-489F-BD8C-105536BA9BBC @default.
- Q95323086 P433 Q95323086-74AFC326-5985-4A87-A0FD-28BF0D954D3A @default.
- Q95323086 P478 Q95323086-10C71643-C276-4DA8-9357-9DAB3E7B56A5 @default.
- Q95323086 P50 Q95323086-0207FBEC-5A32-4102-A638-6892E2EED3D9 @default.
- Q95323086 P50 Q95323086-1AC9176F-4145-4178-BDFF-A4A538765802 @default.
- Q95323086 P50 Q95323086-1E9D6FBA-9CD0-4FE7-BBAF-EAF346BCEB6A @default.
- Q95323086 P577 Q95323086-776D190A-19E6-4F3D-A7D4-D1196C729E96 @default.
- Q95323086 P698 Q95323086-0199838C-262F-4309-90E3-F05DBB23C80E @default.
- Q95323086 P921 Q95323086-3E7223F0-31F2-46B4-809F-E74FBE28599B @default.
- Q95323086 P356 WNL.0000000000009448 @default.
- Q95323086 P698 32423987 @default.
- Q95323086 P1433 Q1161692 @default.
- Q95323086 P1476 "Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323086 P2093 "Franziska Hopfner" @default.
- Q95323086 P2093 "Gregor Kuhlenbäumer" @default.
- Q95323086 P2093 "Günter U Höglinger" @default.
- Q95323086 P2093 "Mette Wod" @default.
- Q95323086 P2093 "Morten Blaabjerg" @default.
- Q95323086 P2093 "Thomas W Rösler" @default.
- Q95323086 P304 "899" @default.
- Q95323086 P31 Q13442814 @default.
- Q95323086 P356 "10.1212/WNL.0000000000009448" @default.
- Q95323086 P433 "20" @default.
- Q95323086 P478 "94" @default.
- Q95323086 P50 Q30119824 @default.
- Q95323086 P50 Q30501407 @default.
- Q95323086 P50 Q47545834 @default.
- Q95323086 P577 "2020-05-01T00:00:00Z" @default.
- Q95323086 P698 "32423987" @default.
- Q95323086 P921 Q11085 @default.